Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Nanoparticle-Based Hydrogel Liquefies Under Pressure for Delivery by Syringe

By LabMedica International staff writers
Posted on 04 Mar 2015
A hydrogel that liquefies under pressure but reforms as a gel when the pressure is released has been recruited as a delivery system for both hydrophobic and hydrophilic anticancer agents.

Investigators at the Massachusetts Institute of Technology (Cambridge, USA) created the hydrogel by mixing PEG-PLA (polyethylene glycol- polymerized lactic acid) nanoparticles with polymeric cellulose. More...
Each polymer chain formed weak bonds with a number of nanoparticles, producing a loosely woven lattice of polymers and nanoparticles. As each attachment point was fairly weak, the bonds disassociated under the mechanical stress of being injected through a syringe. Once the shear forces had abated, the polymers and nanoparticles formed new attachments with different partners, returning the conglomerate to the gel form.

The composition of the gel allowed it to be loaded simultaneously with two different types of drugs. The PEG-PLA nanoparticles had an inner core capable of carrying small-molecule hydrophobic drugs, which include many chemotherapy agents. At the same time, the cellulose polymer, which existed in aqueous solution, could transport hydrophilic molecules such as proteins, including antibodies and growth factors.

A detailed description of the hydrogel as well as results of an in vivo experiment in which gels injected under the skin of mice survived and successfully released two drugs—one hydrophobic and one hydrophilic—over a period of several days, was published in the February 19, 2015, online edition of the journal Nature Communications.

“We are working with really simple materials,” said contributing author Dr. Mark Tibbitt, a postdoctoral researcher at the Massachusetts Institute of Technology. “They do not require any advanced chemical functionalization. Now you have a gel that can change shape when you apply stress to it, and then, importantly, it can re-heal when you relax those forces. That allows you to squeeze it through a syringe or a needle and get it into the body without surgery.”

Related Links:

Massachusetts Institute of Technology



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.